| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis.
|
Nat Genet
|
2010
|
3.15
|
|
2
|
Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases.
|
Hepatology
|
2006
|
2.61
|
|
3
|
The cholangiopathies: disorders of biliary epithelia.
|
Gastroenterology
|
2004
|
2.38
|
|
4
|
A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C.
|
J Hepatol
|
2007
|
1.83
|
|
5
|
Cytokine-stimulated nitric oxide production inhibits adenylyl cyclase and cAMP-dependent secretion in cholangiocytes.
|
Gastroenterology
|
2003
|
1.79
|
|
6
|
Correction of CFTR malfunction and stimulation of Ca-activated Cl channels restore HCO3- secretion in cystic fibrosis bile ductular cells.
|
Hepatology
|
2002
|
1.79
|
|
7
|
Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-/- mice.
|
Hepatology
|
2009
|
1.72
|
|
8
|
Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma.
|
Hepatology
|
2013
|
1.65
|
|
9
|
Ursodeoxycholic acid stimulates cholangiocyte fluid secretion in mice via CFTR-dependent ATP secretion.
|
Gastroenterology
|
2007
|
1.59
|
|
10
|
Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis C.
|
Gut
|
2010
|
1.59
|
|
11
|
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching.
|
Dig Liver Dis
|
2010
|
1.54
|
|
12
|
Comparison between two high-dose methylprednisolone schedules in the treatment of acute hepatic cellular rejection in liver transplant recipients: a controlled clinical trial.
|
Liver Transpl
|
2002
|
1.50
|
|
13
|
"The city of Hepar": rituals, gastronomy, and politics at the origins of the modern names for the liver.
|
J Hepatol
|
2011
|
1.42
|
|
14
|
Emerging roles of Notch signaling in liver disease.
|
Hepatology
|
2014
|
1.39
|
|
15
|
Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice.
|
Hepatology
|
2010
|
1.31
|
|
16
|
ERK1/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice.
|
Gastroenterology
|
2009
|
1.29
|
|
17
|
Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling.
|
Am J Pathol
|
2007
|
1.26
|
|
18
|
Morphological and functional features of hepatic cyst epithelium in autosomal dominant polycystic kidney disease.
|
Am J Pathol
|
2008
|
1.12
|
|
19
|
Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2-/- (Abcb4-/-) mouse cholangiopathy model by promoting biliary HCO⁻₃ output.
|
Hepatology
|
2011
|
1.11
|
|
20
|
Epithelial-mesenchymal interactions in biliary diseases.
|
Semin Liver Dis
|
2011
|
1.11
|
|
21
|
Altered store operated calcium entry increases cyclic 3',5'-adenosine monophosphate production and extracellular signal-regulated kinases 1 and 2 phosphorylation in polycystin-2-defective cholangiocytes.
|
Hepatology
|
2012
|
1.09
|
|
22
|
Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-κB-mediated inflammatory response in mice.
|
Gastroenterology
|
2011
|
1.07
|
|
23
|
Thiazolidinedione treatment inhibits bile duct proliferation and fibrosis in a rat model of chronic cholestasis.
|
World J Gastroenterol
|
2005
|
1.04
|
|
24
|
Notch signaling regulates tubular morphogenesis during repair from biliary damage in mice.
|
J Hepatol
|
2013
|
1.04
|
|
25
|
Epithelial expression of angiogenic growth factors modulate arterial vasculogenesis in human liver development.
|
Hepatology
|
2008
|
1.03
|
|
26
|
Genetic associations in Italian primary sclerosing cholangitis: heterogeneity across Europe defines a critical role for HLA-C.
|
J Hepatol
|
2010
|
1.02
|
|
27
|
Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib.
|
Hepatology
|
2012
|
0.99
|
|
28
|
Timing of reinfection and mechanisms of hepatocellular damage in transplanted hepatitis C virus-reinfected liver.
|
Liver Transpl
|
2002
|
0.99
|
|
29
|
Notch signaling in hepatocellular carcinoma: guilty in association!
|
Gastroenterology
|
2012
|
0.98
|
|
30
|
Nuclear expression of S100A4 calcium-binding protein increases cholangiocarcinoma invasiveness and metastasization.
|
Hepatology
|
2011
|
0.96
|
|
31
|
Notch signalling beyond liver development: emerging concepts in liver repair and oncogenesis.
|
Clin Res Hepatol Gastroenterol
|
2013
|
0.92
|
|
32
|
Vascular biology of the biliary epithelium.
|
J Gastroenterol Hepatol
|
2013
|
0.91
|
|
33
|
Defective regulation of cholangiocyte Cl-/HCO3(-) and Na+/H+ exchanger activities in primary biliary cirrhosis.
|
Hepatology
|
2002
|
0.91
|
|
34
|
Protein kinase A-dependent pSer(675) -β-catenin, a novel signaling defect in a mouse model of congenital hepatic fibrosis.
|
Hepatology
|
2013
|
0.88
|
|
35
|
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease.
|
Dig Liver Dis
|
2010
|
0.87
|
|
36
|
Glibenclamide stimulates fluid secretion in rodent cholangiocytes through a cystic fibrosis transmembrane conductance regulator-independent mechanism.
|
Gastroenterology
|
2005
|
0.86
|
|
37
|
Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria.
|
Liver Transpl
|
2010
|
0.85
|
|
38
|
Malignancies in Primary Sclerosing Cholangitis - A Continuing Threat.
|
Dig Dis
|
2015
|
0.83
|
|
39
|
Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study.
|
J Hepatol
|
2012
|
0.83
|
|
40
|
Liver transplant in cystic fibrosis: a poll among European centers. A study from the European Liver Transplant Registry.
|
Transpl Int
|
2006
|
0.83
|
|
41
|
Isolation and characterization of biliary epithelial and stromal cells from resected human cholangiocarcinoma: a novel in vitro model to study tumor-stroma interactions.
|
Oncol Rep
|
2013
|
0.82
|
|
42
|
Treatment with pegylated interferon and ribavirin for hepatitis C virus-associated severe cryoglobulinemia in a liver/kidney transplant recipient.
|
J Clin Gastroenterol
|
2007
|
0.81
|
|
43
|
Extended right split liver graft for primary transplantation in children and adults.
|
Transpl Int
|
2006
|
0.81
|
|
44
|
Ursodeoxycholate further increases bile-duct cell proliferative response induced by partial bile-duct ligation in rats.
|
Virchows Arch
|
2004
|
0.80
|
|
45
|
Systemic therapy in hepatocellular carcinoma.
|
Clin Liver Dis
|
2011
|
0.78
|
|
46
|
Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma: the egg of columbus or another illusion?
|
Hepatology
|
2013
|
0.77
|
|
47
|
Incidence and management of colorectal cancer in liver transplant recipients.
|
Clin Colorectal Cancer
|
2008
|
0.76
|
|
48
|
Toward a rational management of very early hepatocellular carcinoma.
|
Hepatology
|
2013
|
0.75
|
|
49
|
Hepatic venous pressure gradient (HVPG), serum sodium (SNa), and model of end-stage liver disease score (MELD): prognostic significance and correlations.
|
J Clin Gastroenterol
|
2007
|
0.75
|
|
50
|
Healthcare costs associated with hepatocellular carcinoma and the value of care.
|
Hepatology
|
2013
|
0.75
|
|
51
|
Prognostic prediction in hepatocellular carcinoma: from art to science.
|
J Clin Gastroenterol
|
2008
|
0.75
|
|
52
|
Type I autoimmune hepatitis presenting with acute liver failure in the setting of wild mushroom ingestion.
|
J Clin Gastroenterol
|
2008
|
0.75
|
|
53
|
Isolated idiopathic bile ductular hyperplasia in patients with persistently abnormal liver function tests.
|
J Hepatol
|
2004
|
0.75
|
|
54
|
[Antiplatelet drugs and gastrointestinal bleeding: numquam periclum sine periclo vincitur].
|
Ital Heart J Suppl
|
2005
|
0.75
|
|
55
|
EASL recognition awardee 2013: Professor Jesus Prieto.
|
J Hepatol
|
2013
|
0.75
|